Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2

被引:0
|
作者
D. Thirumal Kumar
L. Jerushah Emerald
C. George Priya Doss
P. Sneha
R. Siva
W. Charles Emmanuel Jebaraj
Hatem Zayed
机构
[1] Vellore Institute of Technology,Department of Integrative Biology, School of Bio Sciences and Technology
[2] Sri Ramachandra Medical College and Research Institute,Faculty of Biomedical Sciences, Technology and Research
[3] Qatar University,Department of Biomedical Sciences, College of Health and Sciences
来源
Metabolic Brain Disease | 2018年 / 33卷
关键词
D-2-hydroxyglutaric aciduria 2; D2HGDH; IDH2; Variant classification; Molecular dynamics;
D O I
暂无
中图分类号
学科分类号
摘要
The 2-hydroxyglutaric aciduria (2-HGA) is a rare neurometabolic disorder that leads to the development of brain damage. It is classified into three categories: D-2-HGA, L-2-HGA, and combined D,L-2-HGA. The D-2-HGA includes two subtypes: type I and type II caused by the mutations in D2HGDH and IDH2 proteins, respectively. In this study, we studied six mutations, four in the D2HGDH (I147S, D375Y, N439D, and V444A) and two in the IDH2 proteins (R140G, R140Q). We performed in silico analysis to investigate the pathogenicity and stability changes of the mutant proteins using pathogenicity (PANTHER, PhD-SNP, SIFT, SNAP, and META-SNP) and stability (i-Mutant, MUpro, and iStable) predictors. All the mutations of both D2HGDH and IDH2 proteins were predicted as disease causing except V444A, which was predicted as neutral by SIFT. All the mutants were also predicted to be destabilizing the protein except the mutants D375Y and N439D. DSSP plugin of the PyMOL and Molecular Dynamics Simulations (MDS) were used to study the structural changes in the mutant proteins. In the case of D2HGDH protein, the mutations I147S and V444A that are positioned in the beta sheet region exhibited higher Root Mean Square Deviation (RMSD), decrease in compactness and number of intramolecular hydrogen bonds compared to the mutations N439D and D375Y that are positioned in the turn and loop region, respectively. While the mutants R140Q and R140QG that are positioned in the alpha helix region of the protein. MDS results revealed the mutation R140Q to be more destabilizing (higher RMSD values, decrease in compactness and number of intramolecular hydrogen bonds) compared to the mutation R140G of the IDH2 protein. This study is expected to serve as a platform for drug development against 2-HGA and pave the way for more accurate variant assessment and classification for patients with genetic diseases.
引用
收藏
页码:1699 / 1710
页数:11
相关论文
共 50 条
  • [1] Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2
    Kumar, D. Thirumal
    Emerald, L. Jerushah
    Doss, C. George Priya
    Sneha, P.
    Siva, R.
    Jebaraj, W. Charles Emmanuel
    Zayed, Hatem
    [J]. METABOLIC BRAIN DISEASE, 2018, 33 (05) : 1699 - 1710
  • [2] IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria
    Kranendijk, Martijn
    Struys, Eduard A.
    van Schaftingen, Emile
    Gibson, K. Michael
    Kanhai, Warsha A.
    van der Knaap, Marjo S.
    Amiel, Jeanne
    Buist, Neil R.
    Das, Anibh M.
    de Klerk, Johannis B.
    Feigenbaum, Annette S.
    Grange, Dorothy K.
    Hofstede, Floris C.
    Holme, Elisabeth
    Kirk, Edwin P.
    Korman, Stanley H.
    Morava, Eva
    Morris, Andrew
    Smeitink, Jan
    Sukhai, Ram N.
    Vallance, Hilary
    Jakobs, Cornelis
    Salomons, Gajja S.
    [J]. SCIENCE, 2010, 330 (6002) : 336 - 336
  • [3] D-2-hydroxyglutaric aciduria Type I: Functional analysis of D2HGDH missense variants
    Pop, Ana
    Struys, Eduard A.
    Jansen, Erwin E. W.
    Fernandez, Matilde R.
    Kanhai, Warsha A.
    van Dooren, Silvy J. M.
    Ozturk, Senay
    van Oostendorp, Justin
    Lennertz, Pascal
    Kranendijk, Martijn
    van der Knaap, Marjo S.
    Gibson, K. Michael
    van Schaftingen, Emile
    Salomons, Gajja S.
    [J]. HUMAN MUTATION, 2019, 40 (07) : 975 - 982
  • [4] D-2-hydroxyglutaric aciduria in a patient with speech delay due to a novel homozygous deletion in the D2HGDH gene
    Phillips, E.
    Sasarman, F.
    Sinasac, D. S.
    Al-Hertani, W.
    [J]. MOLECULAR GENETICS AND METABOLISM REPORTS, 2019, 20
  • [5] Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma
    Krell, Daniel
    Assoku, Mawuelikem
    Galloway, Malcolm
    Mulholland, Paul
    Tomlinson, Ian
    Bardella, Chiara
    [J]. PLOS ONE, 2011, 6 (05):
  • [6] Mutational analysis of D2HGDH and L2HGDH in brain tumours without IDH1 or IDH2 mutations
    Brehmer, S.
    Pusch, S.
    Schmieder, K.
    von Deimling, A.
    Hartmann, C.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2011, 37 (03) : 330 - 332
  • [7] D-2-HYDROXYGLUTARIC ACIDURIA
    NYHAN, WL
    SHELTON, GD
    JAKOBS, C
    HOLMES, B
    BOWE, C
    CURRY, CJR
    VANCE, C
    DURAN, M
    SWEETMAN, L
    [J]. JOURNAL OF CHILD NEUROLOGY, 1995, 10 (02) : 137 - 142
  • [8] Novel cases of D-2-hydroxyglutaric aciduria with IDH1 or IDH2 mosaic mutations identified by amplicon deep sequencing
    Nota, Benjamin
    Hamilton, Eline M.
    Sie, Daoud
    Ozturk, Senay
    van Dooren, Silvy J. M.
    Ojeda, Matilde R. Fernandez
    Jakobs, Cornelis
    Christensen, Ernst
    Kirk, Edwin P.
    Sykut-Cegielska, Jolanta
    Lund, Allan M.
    van der Knaap, Marjo S.
    Salomons, Gajja S.
    [J]. JOURNAL OF MEDICAL GENETICS, 2013, 50 (11) : 754 - 759
  • [9] Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation
    Birgit Geoerger
    Manuel Schiff
    Virginie Penard-Lacronique
    Niklas Darin
    Selim-Maria Saad
    Clarisse Duchon
    Antonin Lamazière
    Aurore Desmons
    Clément Pontoizeau
    Pablo Berlanga
    Stéphane Ducassou
    Katharine Yen
    Michael Su
    David Schenkein
    Chris Ottolenghi
    Stéphane De Botton
    [J]. Nature Medicine, 2023, 29 : 1358 - 1363
  • [10] NOVEL TREATMENT OF TYPE II D-2-HYDROXYGLUTARIC ACIDURIA USING ENASIDENIB, AN IDH2 INHIBITIOR
    Gold, Jessica I.
    Stefanatos, Arianna K.
    Vanderver, Adeline
    Cuddapah, Sanmati
    [J]. MOLECULAR GENETICS AND METABOLISM, 2022, 135 (04) : 274 - 274